tiprankstipranks
Ayala Pharma (NASDAQ:AYLA) Bags Fast Track Status for Desmoid Tumor Candidate
PremiumMarket NewsAyala Pharma (NASDAQ:AYLA) Bags Fast Track Status for Desmoid Tumor Candidate
2y ago
Ayala Pharmaceuticals Announces Fast Track Designation Granted by US FDA for AL102 in Progressing Desmoid Tumors
PremiumPress Releases
Ayala Pharmaceuticals Announces Fast Track Designation Granted by US FDA for AL102 in Progressing Desmoid Tumors
2y ago
Ayala Pharmaceuticals Selected to Present Efficacy and Tolerability Data on AL102 in Desmoid Tumors at the European Society for Medical Oncology (ESMO) 2022 Congress
PremiumPress Releases
Ayala Pharmaceuticals Selected to Present Efficacy and Tolerability Data on AL102 in Desmoid Tumors at the European Society for Medical Oncology (ESMO) 2022 Congress
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100